Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma

Dai Chihara, Jason R. Westin, Roberto N. Miranda, Chan Y. Cheah, Yasuhiro Oki, Francesco Turturro, Jorge E. Romaguera, Sattva S. Neelapu, Lorreta J. Nastoupil, Luis E. Fayad, M. Alma Rodriguez, Nathan H. Fowler, Robert Z. Orlowski, Michael L. Wang, Fredrick B. Hagemeister, L. Jeffrey Medeiros, Michelle A Fanale

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish
Pages (from-to)503-506
JournalBritish Journal of Haematology
Issue number3
Publication statusPublished - 2017
Externally publishedYes

Cite this